Suppression of CYP isoforms in patients with chronic hepatitis c before and after pharmacological treatment depends on the stage of hepatic fibrosis (2021)
- Authors:
- USP affiliated authors: ROCHA, ADRIANA - FCFRP ; PEREIRA, MARIA PAULA MARQUES - FCFRP ; LANCHOTE, VERA LUCIA - FCFRP ; PIPPA, LEANDRO FRANCISCO - FCFRP
- Unidade: FCFRP
- DOI: 10.1002/hep.32188
- Subjects: HEPATITE; DOENÇA CRÔNICA; FIBROSE CÍSTICA; RESULTADO DE TRATAMENTO
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2021
- Source:
- Título: Hepatology
- ISSN: 0270-9139
- Volume/Número/Paginação/Ano: v. 74, suppl. 1, p. 576A-577A, abst. 943, 2021
- Conference titles: The Liver Meeting - American Association for the Study of Liver Diseases (AASLD)
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: other-oa
-
ABNT
PIPPA, Leandro Francisco et al. Suppression of CYP isoforms in patients with chronic hepatitis c before and after pharmacological treatment depends on the stage of hepatic fibrosis. Hepatology. Philadelphia: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/hep.32188. Acesso em: 27 dez. 2025. , 2021 -
APA
Pippa, L. F., Vieira, C. P., Caris, J. A., Rocha, A., Pereira, M. P. M., Garcia, C. P., et al. (2021). Suppression of CYP isoforms in patients with chronic hepatitis c before and after pharmacological treatment depends on the stage of hepatic fibrosis. Hepatology. Philadelphia: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/hep.32188 -
NLM
Pippa LF, Vieira CP, Caris JA, Rocha A, Pereira MPM, Garcia CP, Rezende REF, Lanchote VL. Suppression of CYP isoforms in patients with chronic hepatitis c before and after pharmacological treatment depends on the stage of hepatic fibrosis [Internet]. Hepatology. 2021 ; 74 576A-577A.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1002/hep.32188 -
Vancouver
Pippa LF, Vieira CP, Caris JA, Rocha A, Pereira MPM, Garcia CP, Rezende REF, Lanchote VL. Suppression of CYP isoforms in patients with chronic hepatitis c before and after pharmacological treatment depends on the stage of hepatic fibrosis [Internet]. Hepatology. 2021 ; 74 576A-577A.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1002/hep.32188 - Clinical treatment for hepatitis C reverses CYP2C19 inhibition
- Detection of allopurinol and oxypurinol in canine urine by HPLC/MS-MS: focus on veterinary clinical pharmacokinetics
- Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio
- Simultaneous analysis of the total plasma concentration of atorvastatin and its five metabolites and the unbound plasma concentration of atorvastatin: application in a clinical pharmacokinetic study of single oral dose
- Effect of chronic hepatitis C on the activity of the membrane transporters P‐gp and OATP1B1/BCRP on patients with different stages of hepatic fibrosis
- Influence of gasoline inhalation on the enantioselective pharmacokinetics of fluoxetine in rats
- Analysis of ibuprofen enantiomers in rat plasma by liquid chromatography with tandem mass spectrometry
- Impact of Plasmodium vivax malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients
- Total, unbound, renal, and hepatic clearances of raltegravir and the formation and elimination clearances of raltegravir glucuronide in pregnant Women
- Analysis of daunorubicin and its metabolite daunorubicinol in plasma and urine with application in the evaluation of total, renal and metabolic formation clearances in patients with acute myeloid leukemia
Informações sobre o DOI: 10.1002/hep.32188 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003242356.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
